Medicus Pharma (MDCX) Change in Cash (2024 - 2025)
Medicus Pharma (MDCX) posted Change in Cash of $43127.0 for Q4 2025, up 104.28% quarter-over-quarter from -$1.0 million in Q3 2025, and up 103.78% year-on-year from $21163.8 in Q4 2024.
Medicus Pharma (MDCX) Change in Cash (2024 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has reported Change in Cash for 2 consecutive years, with $43127.0 the latest figure, recorded in Q4 2025.
- Change in Cash for Q4 2025 came in at $43127.0, up 103.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.5 million (up 85.72% YoY), and the FY2025 annual result was $4.5 million, up 85.72% from the prior year.
- Change in Cash was $43127.0 for Q4 2025 at Medicus Pharma, up from -$1.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $7.9 million in Q2 2024 and troughed at -$3.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | -1.99 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.98 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 4.16 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 5.70 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -9.29 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 65.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 563.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Medicus Pharma | 6.91 Mn | -1.69 Mn | - | 43,127.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,127.00 |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | 5.69 Mn |
| Mar 31, 2025 | -181,893.00 |
| Dec 31, 2024 | -1.14 Mn |
| Sep 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | 7.87 Mn |
| Mar 31, 2024 | -1.18 Mn |